MedTrace Logo

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

NCT07182981 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-09-19

No results posted yet for this study

Summary

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance.

Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

Conditions

  • Systemic Sclerosis (SSc)
  • Scleroderma
  • Scleroderma (Limited and Diffuse)
  • Scleroderma, Localized
  • Swallowing

Interventions

OTHER

Questionnaire application for child and adult scleroderma patients

Scales will be applied to cases diagnosed with scleroderma

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2027-08-31
Completion
2027-08-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07182981 on ClinicalTrials.gov